Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	241.64B -3.1%
Revenue (ttm)	860.40B -0.9%
Net Income	14.03B -3.7%
EPS	638.88 -11.5%
Shares Out	21.97M
PE Ratio	17.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,601
Average Volume	10,779
Open	10,700
Previous Close	10,700
Day's Range	10,700 - 11,000
52-Week Range	9,907 - 12,150
Beta	0.49
RSI	59.46
Earnings Date	Apr 29, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 684
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2025, HOSE:DBT's revenue was 860.40 billion, a decrease of -0.92% compared to the previous year's 868.41 billion. Earnings were 14.03 billion, an increase of 4.07%.